A microfluidic-chip-based analysis platform specially tuned for characterizing individual nanobio-particles has been developed. Using this platform, both artificial nanobioparticles (polyion complex vesicles) and cell-secreted exosomes with diameter down to 50 nm can be observed. The zeta potential distribution of the exosomes was obtained by measuring the zeta potential of individual exosomes. Since the number of surface molecules on nanobioparticles can be estimated by applying a particle immunoelectrophoresis method, this platform is promising for obtaining profiles of heterogeneous nanobioparticles including nanoDDS carriers and exosomes.
Introduction
Applying nanobioparticles has drawn considerable attention in the field of medicine. For example, artificially prepared vesicles with a diameter of 10-100 nm order are used in drug delivery systems (DDSs). Nanoliposomes and nanomicelles are used as smart carriers of encapsulated drugs that remain in the blood for a long time and accumulate at pathological sites [1, 2] . In particular, these particles with a diameter of 10 nm order tend to accumulate in solid tumor tissue more than in normal tissues via the enhanced permeability and retention (EPR) effect [3] . Moreover, active-targeted drug delivery using specific ligand-modified nanobioparticles is expected to enhance the therapeutic efficacy of drugs by carrying drugs into poorly accessible areas and increasing the cellular uptake of nanobioparticles via receptor-mediated endocytosis [4, 5] .
On the other hand, extracellular vesicles including exosomes are being focused on as mediators of intercellular signaling. Exosomes are small vesicles (30-100 nm) that are generated in the multivesicular bodies (MVBs), and they are released from secretory MVBs upon fusion with a plasma membrane (Fig. 1 ) [6] [7] [8] . Because exosomes contain specific genetic materials such as proteins, messenger RNA (mRNA), and microRNA (miRNA) derived from the parent cells, they regulate gene expression in recipient cells at the post-transcriptional level [6, 9, 10] . Additionally, exosomes are considered to be promising biomarkers for the diagnosis of various diseases such as cancer [11] [12] [13] . To further extend the application technologies of nanobioparticles, their accurate characterization is important. The size and zeta potential are fundamental physical properties of nanobioparticles. In addition, characterization of the surface molecules on nanobioparticles including the specific ligand of carriers and the marker protein of exosomes, is a key issue in nanobioparticle application [13] [14] [15] . Particle-by-particle measurements are required owing to the heterogeneity of nanobioparticles. However, fluorescence-labeled particles with diameters of 100 nm and above can be detected by high-resolution fluorescent flow cytometry [16] . Moreover, the use of high-power lasers usually induces the problematic phenomenon of photobleaching.
Recently, we have developed an on-chip microcapillary electrophoresis ( CE) platform equipped with a laser-dark field microscope that enables the zeta potential of individual nanobioparticles to be obtained [17] [18] [19] . Additionally, an analytical method for profiling the surface proteins of individual exosomes that employs the principle of on-chip particle immunoelectrophoresis has been proposed [19] . Using the system, surface proteins can be analyzed at the single-particle level. However, higher sensitivity of the imaging system is necessary to improve the performance of the methodology. In this study, the optimization of laser dark-field imaging on microfluidic chips was investigated.
Method 1. Microfluidic-chip-based platform
The microfluidic-chip-based platform for nanobio-particles was developed in our laboratory and is shown in Fig. 2(a) [18, 19] . Briefly, the platform comprises a microcapillary electrophoresis ( CE) chip, a pair of platinum electrodes, a DC power supply [Matsusada Precision HVL-1.1P(A)], a 404 nm laser source (Coherent Obis laser system, 50 mW), a microscope (Nikon, Ti-U), and a COMS camera (Andor Neo sCOMS). Poly(dimethylsiloxane) (PDMS)-based a soft lithography method [20, 21] . A laser beam was shaped by cylindrical lens as shown in Fig. 2(b) . To suppress nonspecific adsorption and the generation of an electroosmotic flow (EOF), the width, 2 20 phospholipid copolymer containing 2-methacryloyloxyethyl phosphorylcholine (MPC) and 3-methacryloxyethyl triethoxysilane (METESi) [22, 23] . 
Size distribution measurement
The size distribution of the PICsomes and exosomes was evaluated by a DLS method and nanoparticle tracking analysis (NTA). The DLS measurements were conducted using a Zetasizer Nano-ZS system (Malvern Instruments, U.K.) equipped with a He-Ne laser operating at 633 nm [24] . The NTA was performed using our microfluidic-chip-based system. After sample was introduced into the microchannel of a chip, the Brownian motion of each particle was visualized by a light scattering method and recorded for 0.1 s and its hydrodynamic diameter was calculated using the Stokes-Einstein equation.
3. Zeta potential measurement
Zeta potential of individual exosomes was evaluated by a procedure described previously [17] [18] [19] . Briefly, after of a sample chip, the chip was placed on the stage of an inverted microscope, and then electrodes were dipped into the reservoirs at both ends of the microchannel. The electrophoresis experiment was performed by applying an electric field of 30 V/cm in the microchannel. The migration velocity of exosomes was measured from the recorded video. After measuring the EOF velocity, U eo , using charge-free beads, the true electrophoretic velocity of the exosomes, U ep , was calculated by subtracting U eo from their measured velocity, U m . The zeta potential of using the Smoluchowski equation
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, (1) where E is the electric field strength, is the viscosity coefficient of the buffer solution, and r and 0 are the relative permittivity of the solution and the permittivity of vacuum, respectively.
Results and discussion
To obtain the characteristics of small nanobioparticles by tracking analysis, a high-contrast imaging system is required. Hence, the laser beam irradiation was improved to reduce background noise as shown in Fig. 2(b) . The lower detection limit of our microfluidic-chip-based platform was examined using polyion complex vesicles (PICsomes), which were kindly provided by Dr. Anraku and Prof. Kataoka at University of Tokyo. Figure 3(a) shows the diameter distribution of the PICsomes evaluated by dynamic light scattering (DLS). The diameter of the PICsomes was normally distributed with a mean of 100 nm [24] . Figure 3(b) shows the diameter distribution of the PICsomes evaluated using the microfluidic-chip-based platform. PICsomes with diameters between 47 and 347 nm were measured, and the mean and standard deviation were 132 and 55 nm, respectively. It was thus confirmed that this platform is useful for evaluating artificially prepared vesicles with a diameter of up to 50 nm.
Because the intensity of light scattered by a nanobioparticle depends on its refractive index, not all types of nanobioparticle can be observed. Hence, the observation of individual exosomes using our platform was examined. Exosome samples of human fibrosarcoma cell line (H1080) were kindly provided by Dr. Minamizawa and Dr. Shiba at Japanese Foundation for Cancer Research. These samples were extracted from a culture supernatant of H1080 cells by differential centrifugation and an Opti-Prep density-gradient ultracentrifugation. Figure 4 shows the diameter distribution of the exosomes measured using our platform. Exosomes with diameters between 53 and 404 nm were observed, and the mean and standard deviation were 135 and 56 nm, respectively. These results show that our platform is suitable for obtaining the diameter of individual exosomes. Fig. 4 . Distribution of diameter of exosomes evaluated using our microfluidic chip-based platform. Exosomes with diameter of up to 53 nm can be evaluated using this platform.
As described above, our microchip-based platform is suitable for the tracking analysis of individual nanobio-particles. Hence, a further experiment on evaluating the zeta potential of individual exosomes was performed using our platform. Figure 5 shows the zeta potential distribution of exosomes purified from a culture supernatant of H1080 cells. Exosomes with zeta potentials between -3.0 and -21 mV were measured, and the mean and standard deviation were -12 and -3.6 mV, respectively. Since the expression level of surface proteins on exosomes can be estimated from difference in the zeta potential before and after an immunoreaction, two-dimensional histograms of diameter and protein expression level of individual exosomes are expected to be obtained in the near future. 
Conclusion
We have developed an on-chip tuned for characterizing individual nanobioparticles. Using this platform, both artificial nanobioparticles such as PICsomes and cell-secreted exosomes with diameter down to 50 nm can be observed. Our microfluidic-chip-based platform is expected to make a substantial contribution to technologies using nanobioparticles such as nanoDDS and exosomal diagnosis.
